We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clazosentan in Aneurysmal Subarachnoid Hemorrhage (CONSCIOUS-3)

This study has been terminated.
(Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2))
Sponsor:
ClinicalTrials.gov Identifier:
NCT00940095
First Posted: July 15, 2009
Last Update Posted: May 15, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Actelion
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: March 22, 2011
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):